PRODUCT

TB-500 (10mg) + BPC-157 (10mg) Wolverine 20mg

No short description available.

Quickstart Highlights

BPC-157 + TB-500 combines two extensively researched peptides recognized for their complementary roles in regenerative medicine. BPC-157 is studied for its potential to support tissue repair, cellular protection, and gastrointestinal, musculoskeletal, and nervous system health, while TB-500 is investigated for its involvement in cell migration, angiogenesis, and wound healing. Together, they provide a synergistic combination for research focused on tissue regeneration and recovery.

Reconstitution: Add 3.0 mL of bacteriostatic water to obtain a final concentration of approximately 6.67 mg/mL (3.33 mg/mL of each peptide).
Typical Daily Range: 250–500 mcg of BPC-157 + 250–500 mcg of TB-500 (500–1,000 mcg total blend) administered once daily.
Easy Measurement: At a concentration of 6.67 mg/mL, 1 unit (0.01 mL) on a U-100 insulin syringe delivers approximately 66.7 mcg of the total blend (≈33.3 mcg of each peptide).
Storage: Lyophilized product: store frozen at −20 °C (−4 °F). After reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 14 days.

Reconstitution

Draw 3.0 mL of bacteriostatic water using a sterile syringe.
Slowly inject the diluent down the inside wall of the vial, avoiding foaming or directing the stream onto the lyophilized powder.
Gently swirl or roll the vial until the contents are completely dissolved. Do not shake.
Label the vial with the reconstitution date and store refrigerated at 2–8 °C (35.6–46.4 °F), protected from light.

Protocol Overview

Goal:Support research into tissue repair, wound healing, musculoskeletal recovery, and regenerative processes.
Schedule:Daily subcutaneous injections for 4–8 weeks; some research protocols include 3 months on followed by 6 weeks off.
Dose Range:500–1,500 mcg of the total blend per day (approximately 250–750 mcg of each peptide).
Reconstitution:Add 3.0 mL of bacteriostatic water to each 20 mg vial to obtain a final concentration of approximately 6.67 mg/mL for accurate dosing.
Storage:Store the lyophilized product frozen at −20 °C (−4 °F). After reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 14 days.

Dosage Protocols

Starting Dose:500–666 mcg of the total blend daily (approximately 250–333 mcg of each peptide).
Target Dose:Increase to 1,000 mcg of the total blend daily (approximately 500 mcg of each peptide) during Weeks 3–8.
Frequency:Once daily by subcutaneous injection.
Cycle Length:4–8 weeks; optional cycling with 6-week breaks between treatment courses.
Administration Time:Administer at any consistent time of day. Morning administration is commonly preferred. Rotate injection sites regularly.

Storage Instructions

Lyophilized:Store at −20 °C (−4 °F) in a dry, dark environment. Minimize exposure to moisture and direct light.
Reconstituted:Refrigerate at 2–8 °C (35.6–46.4 °F) and use within 14 days. Avoid repeated freeze-thaw cycles.

Important Notes

Use a new sterile insulin syringe for every injection and dispose of it immediately in an approved sharps container.
Rotate injection sites (abdomen, outer thighs, and upper arms) to help reduce local irritation and promote consistent absorption.
When studying localized tissue repair, injections are commonly administered near the affected area, when anatomically appropriate.
Record the daily dose, injection site, and any observations to maintain consistency throughout the research protocol.
BPC-157 and TB-500 are listed as prohibited substances by the World Anti-Doping Agency (WADA) for competitive sports.

How It Works

BPC-157 + TB-500 combines two complementary peptides involved in tissue repair and regenerative research. BPC-157 is a synthetic 15-amino acid peptide originally derived from human gastric juice and is studied for its cytoprotective properties, its role in supporting angiogenesis, modulating nitric oxide signaling, and promoting pathways associated with tissue repair. TB-500, a synthetic version of the naturally occurring Thymosin β4, regulates actin polymerization, promotes cell migration, helps modulate the inflammatory response, and supports wound healing and tissue regeneration. Together, these peptides are investigated for their complementary mechanisms that may enhance musculoskeletal and soft-tissue recovery.

Lifestyle Factors

Nutrition: Prioritize adequate protein intake to support tissue synthesis, repair, and recovery.
Rehabilitation: Combine with appropriate rehabilitation or physical therapy protocols when researching musculoskeletal injuries.
Sleep & Stress Management: Aim for 7–9 hours of quality sleep and incorporate stress-management practices to help optimize recovery and healing responses.
Hydration & Micronutrients: Stay well hydrated and maintain adequate intake of essential micronutrients such as vitamins C and D, and zinc, to support connective tissue health.

Injection Technique

Site Preparation: Clean the vial stopper and injection site with an alcohol swab. Allow the alcohol to dry completely before proceeding.
Injection Angle: Pinch a fold of skin and insert the needle at a 45°–90° angle into the subcutaneous tissue (typically using a 23–25 gauge, 5/8-inch needle).
Administration: Do not aspirate before a subcutaneous injection. Inject the solution slowly and steadily.
Site Rotation: Rotate injection sites systematically between the abdomen, outer thigh, upper arm, and buttocks to help prevent lipohypertrophy and local irritation.
Localized Administration: When researching localized injuries, administer the injection subcutaneously near (not directly into) the affected area whenever anatomically appropriate.

TB-500 (10mg) + BPC-157 (10mg) Wolverine 20mg

Resources

Categories

Company